Skip to main content
. 2014 Jul 8;5:158. doi: 10.3389/fphar.2014.00158

Table 1.

Study Completers: Behavioral and Clinical Measures.

Characteristic Baseline (Pre-drug) Week 12 (Post-drug) t-value p-value
SMOKING BEHAVIOR
CO* 19.27 ± 8.48 4.36 ± 5.70 6.71 <0.001
CPD 23.60 ± 9.20 2 ± 4.4 9.01 <0.001
STROOP TASK BEHAVIOR
Congruent RT 799 ± 14 762 ± 9 2.36 0.04
Incongruent RT 956 ± 17 918 ± 13 1.73 0.12
Stroop effect RT 154 ± 8 158 ± 6 −0.29 0.78
Task errors 4.36 ± 2.94 11.27 ± 18.00 −1.24 0.24
CLINICAL MEASURES**
FTND 5.89 ± 2.0
MNWS 9.22 ± 5.61 6.00 ± 6.67 1.04 0.33
QSU-brief 39.11 ± 15.37 11.89 ± 3.52 4.54 0.002
SPSRQ 14.44 ± 5.92 16.44 ± 7.59 −1.73 0.12
CESD 9.67 ± 4.24 9.33 ± 4.64 0.23 0.83
SSE 45.44 ± 12.07 38.67 ± 8.02 1.64 0.14

CESD, Center for Epidemiological Studies on Depression; CO, carbon monoxide; CPD, cigarettes per day; FTND, Fagerström Test for Nicotine Addiction; MNWS, Minnesota Nicotine Withdrawal Scale (Hughes-Hatsukami Withdrawal Scale); RT, reaction time in milliseconds; SPSRQ, Sensitivity to Punishment and Sensitivity to Reward Questionnaire; SSE, Symptoms and Side Effects; QSU-brief Questionnaire of Smoking Urges Short Form.

FTND week 12 scores have been omitted. Two of the seven items on the FTND are related to recent smoking behavior. Because subjects are enrolled in a study to reduce smoking behavior, reduced scores on this measure may reflect behavioral changes and not nicotine dependence per se.

*

scores imputed for two participants.

**

scores missing for two participants.